دورية أكاديمية
Systematic literature review of the impact of psychiatric pharmacists.
| العنوان: | Systematic literature review of the impact of psychiatric pharmacists. |
|---|---|
| المؤلفون: | Ho JL; Clinical Pharmacist, St. Peter Regional Treatment Center, St. Peter, Minnesota.; Director of Strategic Initiatives, American Association of Psychiatric Pharmacists, Lincoln, Nebraska.; Pain Management/Substance Use Disorder Clinical Pharmacy Practitioner, VISN 20 Clinical Resource Hub, Boise, Idaho.; Clinical Pharmacy Specialist- Behavioral Health, Adventist HealthCare Shady Grove Medical Center, Rockville, Maryland.; Medical Science Liaison, Medical Affairs, Braeuburn, Plymouth Meeting, Pennsylvania; Chicago College of Pharmacy, Midwestern University, Downers Grove, Illinois.; Founder and Consultant, Capita Consulting, Billings, Montana.; National Program Manager, Clinical Pharmacy, Clinical Practice Integration and Model Advancement Pharmacy Benefits Management (PBM), Colorado.; Professor of Clinical Pharmacy, University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California., Roberts J; Clinical Pharmacist, St. Peter Regional Treatment Center, St. Peter, Minnesota., Payne GH; Director of Strategic Initiatives, American Association of Psychiatric Pharmacists, Lincoln, Nebraska., Holzum DN; Pain Management/Substance Use Disorder Clinical Pharmacy Practitioner, VISN 20 Clinical Resource Hub, Boise, Idaho., Wilkoff H; Clinical Pharmacy Specialist- Behavioral Health, Adventist HealthCare Shady Grove Medical Center, Rockville, Maryland., Tran T; Medical Science Liaison, Medical Affairs, Braeuburn, Plymouth Meeting, Pennsylvania; Chicago College of Pharmacy, Midwestern University, Downers Grove, Illinois., Cobb CD; Founder and Consultant, Capita Consulting, Billings, Montana., Moore TD; National Program Manager, Clinical Pharmacy, Clinical Practice Integration and Model Advancement Pharmacy Benefits Management (PBM), Colorado., Lee KC; Professor of Clinical Pharmacy, University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California. |
| المصدر: | The mental health clinician [Ment Health Clin] 2024 Feb 01; Vol. 14 (1), pp. 33-67. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024). |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: College of Psychiatric and Neurologic Pharmacists Country of Publication: United States NLM ID: 101728585 Publication Model: eCollection Cited Medium: Internet ISSN: 2168-9709 (Electronic) Linking ISSN: 21689709 NLM ISO Abbreviation: Ment Health Clin Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Lincoln, NE : College of Psychiatric and Neurologic Pharmacists, [2011]- |
| مستخلص: | Introduction: Pharmacists focusing on psychotropic medication management and practicing across a wide variety of healthcare settings have significantly improved patient-level outcomes. The Systematic Literature Review Committee of the American Association of Psychiatric Pharmacists was tasked with compiling a comprehensive database of primary literature highlighting the impact of psychiatric pharmacists on patient-level outcomes. Methods: A systematic search of literature published from January 1, 1961, to December 31, 2022, was conducted using PubMed and search terms based on a prior American Association of Psychiatric Pharmacists literature review. Publications describing patient-level outcome results associated with pharmacist provision of care in psychiatric/neurologic settings and/or in relation to psychotropic medications were included. The search excluded articles for which there was no pharmacist intervention, no psychiatric disorder treatment, no clinical outcomes, no original research, no access to full text, and/or no English-language version. Results: A total of 4270 articles were reviewed via PubMed, with 4072 articles excluded based on title, abstract, and/or full text in the initial pass and 208 articles selected for inclusion. A secondary full-text review excluded 11 additional articles, and 5 excluded articles were ultimately included based on a secondary review, for a final total of 202 articles meeting the inclusion criteria. A comprehensive database of these articles was compiled, including details on their study designs and outcomes. Discussion: The articles included in the final database had a wide range of heterogeneity. While the overall impact of psychiatric pharmacists was positive, the study variability highlights the need for future publications to have more consistent, standardized outcomes with stronger study designs. Competing Interests: Disclosures: The authors have no conflicts of interest to disclose. (© 2024 AAPP. The Mental Health Clinician is a publication of the American Association of Psychiatric Pharmacists.) |
| References: | Drug Alcohol Depend. 2022 Jul 1;236:109465. (PMID: 35490592) Saudi Pharm J. 2018 Dec;26(8):1204-1207. (PMID: 30510473) Am J Hosp Pharm. 1977 Jun;34(6):604-8. (PMID: 879182) Fed Pract. 2022 Jul;39(7):304-309. (PMID: 36425350) Cancer Causes Control. 2011 Feb;22(2):167-80. (PMID: 21153694) Am J Hosp Pharm. 1994 Apr 1;51(7):895-9. (PMID: 7912473) Psychiatr Serv. 2011 Nov;62(11):1282-8. (PMID: 22211206) J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):36-43. (PMID: 11833513) Am J Health Syst Pharm. 1995 Feb 1;52(3):287-93. (PMID: 7749956) J Am Pharm Assoc (2003). 2015 Mar-Apr;55(2):187-92. (PMID: 25749264) Nicotine Tob Res. 2011 Feb;13(2):135-45. (PMID: 21196451) BMJ. 2001 Mar 17;322(7287):654-7. (PMID: 11250852) Pharmacotherapy. 2003 Feb;23(2):217-21. (PMID: 12587811) Patient Prefer Adherence. 2015 Jan 29;9:209-15. (PMID: 25678779) J Natl Med Assoc. 2011 Jul;103(7):567-74. (PMID: 21999031) Ment Health Clin. 2018 Apr 26;8(3):105-109. (PMID: 29955554) Ment Health Clin. 2018 Mar 23;7(3):101-105. (PMID: 29955506) Australas J Ageing. 2021 Dec;40(4):356-365. (PMID: 33166034) Health Qual Life Outcomes. 2010 Jun 18;8:59. (PMID: 20565872) Hosp Pharm. 2022 Feb;57(1):26-31. (PMID: 35521002) Prev Chronic Dis. 2022 Jul 14;19:E41. (PMID: 35834737) Br J Gen Pract. 2021 May 27;71(707):e458-e464. (PMID: 33947668) Can J Hosp Pharm. 2018 May-Jun;71(3):180-186. (PMID: 29955191) Yakugaku Zasshi. 2016;136(9):1243-54. (PMID: 27592827) Am J Health Syst Pharm. 2008 Feb 1;65(3):229-33. (PMID: 18216008) Pharmacy (Basel). 2021 Jan 14;9(1):. (PMID: 33466912) Ment Health Clin. 2022 Jun 10;12(3):187-192. (PMID: 35801158) Ann Pharmacother. 2002 Apr;36(4):585-91. (PMID: 11918503) Am J Health Syst Pharm. 2002 Aug 15;59(16):1518-26. (PMID: 12185826) Ment Health Clin. 2021 Jul 16;11(4):248-253. (PMID: 34316421) Clin Transl Sci. 2021 Jul;14(4):1359-1368. (PMID: 33641259) JAMA Psychiatry. 2015 Jan;72(1):58-67. (PMID: 25409287) Eur Neuropsychopharmacol. 2013 Sep;23(9):1057-66. (PMID: 23219937) J Urban Health. 2011 Aug;88(4):718-23. (PMID: 21512832) J Clin Hosp Pharm. 1986 Jun;11(3):207-14. (PMID: 3745470) J Am Pharm Assoc (2003). 2020 Sep - Oct;60(5S):S98-S106. (PMID: 32665098) Ment Health Clin. 2020 Nov 05;10(6):358-380. (PMID: 33224694) Int J Environ Res Public Health. 2022 Jul 06;19(14):. (PMID: 35886120) J Manag Care Spec Pharm. 2014 Jun;20(6):579-87. (PMID: 24856596) Med J Malaysia. 2015 Jun;70(3):131-41. (PMID: 26248774) Hosp Pharm. 1978 Feb;13(2):78, 81-2, 84 passim. (PMID: 10306348) J Pediatr Pharmacol Ther. 2022;27(8):720-724. (PMID: 36415769) Br J Psychiatry. 2000 Jun;176:563-7. (PMID: 10974963) Pharmacotherapy. 2000 May;20(5):583-8. (PMID: 10809346) J Manag Care Spec Pharm. 2017 Jan;23(1):74-84. (PMID: 28025928) Drug Intell Clin Pharm. 1984 Jul-Aug;18(7-8):632-4. (PMID: 6745092) Health Serv Res. 2018 Aug;53(4):2547-2566. (PMID: 28891153) Patient Educ Couns. 2018 May;101(5):862-871. (PMID: 29336859) J Am Pharm Assoc (2003). 2011 Sep-Oct;51(5):599-604. (PMID: 21896457) J Prim Care Community Health. 2016 Apr;7(2):118-21. (PMID: 26582045) Singapore Med J. 2019 Jan;60(1):31-33. (PMID: 29774362) Am J Health Syst Pharm. 2012 Mar 15;69(6):518-20. (PMID: 22382484) Ann Pharmacother. 2011 Nov;45(11):1346-55. (PMID: 22028418) BMC Public Health. 2017 Feb 20;17(1):215. (PMID: 28219367) Pharmacy (Basel). 2018 Jan 16;6(1):. (PMID: 29337859) Can Pharm J (Ott). 2021 Jun 11;154(4):278-284. (PMID: 34345321) Drug Intell Clin Pharm. 1988 Mar;22(3):205-8. (PMID: 2896586) J Opioid Manag. 2014 May-Jun;10(3):159-68. (PMID: 24944066) Fam Syst Health. 2017 Jun;35(2):217-226. (PMID: 28617022) BMC Res Notes. 2012 Jan 06;5:9. (PMID: 22226240) Can Pharm J (Ott). 2016 Sep;149(5):303-312. (PMID: 27708676) J Hepatol. 2013 Nov;59(5):926-33. (PMID: 23811030) Am J Pharm Educ. 2010 Nov 10;74(9):163. (PMID: 21301597) Can Pharm J (Ott). 2022 Oct 12;155(6):334-344. (PMID: 36386606) J Pediatr Pharmacol Ther. 2014 Jul;19(3):165-73. (PMID: 25309146) J Pharm Pract. 2022 Oct 31;:8971900221137100. (PMID: 36314582) JAMA Health Forum. 2022 Sep 2;3(9):e223378. (PMID: 36218952) Psychopharmacol Bull. 2018 Feb 5;48(2):18-28. (PMID: 29713097) Sci Rep. 2021 Jul 1;11(1):13641. (PMID: 34211019) Eur J Clin Pharmacol. 2023 Feb;79(2):289-297. (PMID: 36562830) J Am Pharm Assoc. 1974 May;14(5):252-6 passim. (PMID: 4831215) Ment Health Clin. 2019 Mar 01;9(2):70-75. (PMID: 30842913) J Manag Care Spec Pharm. 2016 Dec;22(12):1417-1425. (PMID: 27882838) Int J Clin Pharm. 2019 Oct;41(5):1138-1142. (PMID: 31493208) Springerplus. 2015 Sep 02;4:470. (PMID: 26357601) J Am Pharm Assoc (2003). 2009 Nov-Dec;49(6):760-8. (PMID: 19926556) Nicotine Tob Res. 2002;4 Suppl 1:S19-24. (PMID: 11945215) Patient Educ Couns. 2008 Jul;72(1):94-101. (PMID: 18337052) J Am Pharm Assoc (2003). 2021 Nov-Dec;61(6):e93-e98. (PMID: 34330650) Ment Health Clin. 2022 Jun 10;12(3):193-198. (PMID: 35801163) J Clin Pharm Ther. 1993 Jun;18(3):183-6. (PMID: 8102143) Can Pharm J (Ott). 2022 Apr 15;155(3):175-180. (PMID: 35519083) J Pharm Pract. 2023 Oct;36(5):1201-1210. (PMID: 35484711) Ann Pharmacother. 2018 Nov;52(11):1109-1116. (PMID: 29857773) Prev Cardiol. 2008 Fall;11(4):195-200. (PMID: 19476571) S Afr Med J. 1990 Nov 17;78(10):587-90. (PMID: 2247792) PLoS One. 2022 Mar 29;17(3):e0265483. (PMID: 35349576) Sci Rep. 2019 Nov 14;9(1):16856. (PMID: 31728029) Pharm World Sci. 2009 Oct;31(5):550-558. (PMID: 19633917) BMC Psychiatry. 2015 Sep 16;15:219. (PMID: 26376830) J Gen Intern Med. 2022 Aug;37(11):2624-2633. (PMID: 35132556) J Pharm Pract. 2017 Aug;30(4):425-433. (PMID: 27480874) Addiction. 2015 Oct;110(10):1586-94. (PMID: 25988589) Ann Pharmacother. 2005 Dec;39(12):2015-20. (PMID: 16288070) Am J Hosp Pharm. 1976 Jul;33(7):635-8. (PMID: 941914) Pharmacopsychiatry. 2020 Jul;53(4):185-192. (PMID: 32045941) Patient Prefer Adherence. 2012;6:605-11. (PMID: 22969291) J Eval Clin Pract. 2020 Oct;26(5):1478-1489. (PMID: 31692212) Ment Health Clin. 2018 Mar 23;7(3):111-115. (PMID: 29955508) J Manag Care Pharm. 2013 Apr;19(3):218-27. (PMID: 23537456) Public Health Rep. 1978 Sep-Oct;93(5):464-7. (PMID: 212774) J Pharm Pract. 2022 Dec;35(6):827-835. (PMID: 33827316) J Subst Abuse Treat. 2021 Nov;130:108440. (PMID: 34118708) Ment Health Clin. 2020 Nov 05;10(6):346-353. (PMID: 33224692) Int J Equity Health. 2021 Jan 7;20(1):19. (PMID: 33413396) Asian J Psychiatr. 2019 Aug;44:189-194. (PMID: 31408799) Am J Psychiatry. 2013 Apr;170(4):414-25. (PMID: 23429924) J Clin Pharm Ther. 2022 Dec;47(12):2074-2082. (PMID: 36543253) Epilepsy Behav. 2022 Apr;129:108559. (PMID: 35180569) Pharm Pract (Granada). 2011 Jul;9(3):122-7. (PMID: 24367465) J Am Pharm Assoc (2003). 2020 May - Jun;60(3S):S65-S69. (PMID: 32439280) Scott Med J. 2021 Aug;66(3):134-141. (PMID: 34225517) Farm Hosp. 2019 Jul 01;43(4):140-145. (PMID: 31276444) Saudi Pharm J. 2022 Jul;30(7):1027-1035. (PMID: 35903532) Heliyon. 2020 Feb 11;6(2):e03333. (PMID: 32072044) Front Genet. 2021 Aug 03;12:644694. (PMID: 34413872) Hosp Pharm. 1994 Mar;29(3):228-30, 233-4, 237. (PMID: 10132698) Addiction. 2001 Feb;96(2):325-31. (PMID: 11182878) J Clin Psychiatry. 1979 Dec;40(12):501-3. (PMID: 500572) J Am Pharm Assoc (2003). 2005 May-Jun;45(3):344-53. (PMID: 15991756) Am J Health Syst Pharm. 2004 Feb 15;61(4):364-72. (PMID: 15011764) J Am Pharm Assoc (2003). 2019 Sep - Oct;59(5):698-703. (PMID: 31324536) Int J Environ Res Public Health. 2021 Nov 12;18(22):. (PMID: 34831660) Clin Neuropharmacol. 2018 Jan/Feb;41(1):14-19. (PMID: 29300205) J Clin Pharm Ther. 1996 Feb;21(1):45-8. (PMID: 8737183) Am J Health Syst Pharm. 2017 Feb 15;74(4):253-262. (PMID: 28179250) Integr Pharm Res Pract. 2018 Oct 26;7:161-171. (PMID: 30464898) Eur J Hosp Pharm. 2020 Jan;27(1):31-35. (PMID: 32064086) Schizophr Bull. 2011 Jul;37(4):727-36. (PMID: 19933540) Addict Behav. 2022 Jun;129:107282. (PMID: 35184003) Arch Intern Med. 2011 Jan 10;171(1):23-31. (PMID: 21220657) Addiction. 2000 Jul;95(7):1055-68. (PMID: 10962770) Prim Care Companion CNS Disord. 2014 Oct 30;16(5):. (PMID: 25667811) Contemp Pharm Pract. 1979 Summer;2(3):108-16. (PMID: 10242843) Nicotine Tob Res. 2022 Nov 12;24(12):2011-2017. (PMID: 35862219) Pharmacy (Basel). 2018 Dec 22;7(1):. (PMID: 30583547) Psychiatr Serv. 2016 Oct 1;67(10):1076-1082. (PMID: 27364808) Pharmacotherapy. 2014 Dec;34(12):1336-40. (PMID: 25329409) Hosp Community Psychiatry. 1981 Sep;32(9):639-40. (PMID: 7275041) J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1891-1896.e2. (PMID: 35970728) Int Psychogeriatr. 1989 Fall;1(2):177-84. (PMID: 2491144) Arch Gen Psychiatry. 2010 Aug;67(8):812-21. (PMID: 20679589) PLoS One. 2022 Oct 21;17(10):e0276402. (PMID: 36269748) BMC Health Serv Res. 2022 Jan 12;22(1):58. (PMID: 35022056) J Pharm Policy Pract. 2021 Dec 20;14(1):109. (PMID: 34930487) J Gerontol A Biol Sci Med Sci. 2013 Mar;68(3):271-8. (PMID: 22982689) Ment Health Clin. 2022 Aug 23;12(4):219-224. (PMID: 36071740) J Manag Care Pharm. 2013 Apr;19(3):228-36. (PMID: 23537457) Am J Health Syst Pharm. 2018 Jul 1;75(13):982-986. (PMID: 29941537) Am Pharm. 1995 Aug;NS35(8):20-9; 32. (PMID: 7677052) J Am Pharm Assoc (2003). 2019 Mar - Apr;59(2):258-264. (PMID: 30552050) J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1422-1429. (PMID: 35365405) Pharm Pract (Granada). 2022 Apr-Jun;20(2):2650. (PMID: 35919807) Pediatr Crit Care Med. 2014 Mar;15(3):206-10. (PMID: 24448326) Gen Hosp Psychiatry. 2004 May-Jun;26(3):210-8. (PMID: 15121349) Res Social Adm Pharm. 2020 May;16(5):689-698. (PMID: 31420190) Ment Health Clin. 2016 Aug 31;6(5):260-265. (PMID: 29955480) Subst Abus. 2017 Apr-Jun;38(2):157-160. (PMID: 28166464) Pharmacy (Basel). 2021 Aug 19;9(3):. (PMID: 34449711) Ment Health Clin. 2019 Jul 01;9(4):269-274. (PMID: 31293846) Pharmacotherapy. 2002 Jun;22(6):759-65. (PMID: 12066966) Ment Health Clin. 2019 May 10;9(3):138-140. (PMID: 31123662) Int J Clin Pharm. 2012 Oct;34(5):746-56. (PMID: 22810890) J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):51-6. (PMID: 11833517) Int J Pharm Pract. 2014 Feb;22(1):4-12. (PMID: 23822820) J Pharm Pharm Sci. 2015;18(5):705-12. (PMID: 26670367) Consult Pharm. 2012 Jan;27(1):49-57. (PMID: 22231998) AIDS Behav. 2020 Dec;24(12):3522-3532. (PMID: 32415615) BMJ Open. 2013 Apr 05;3(4):. (PMID: 23562814) J Am Geriatr Soc. 2015 Mar;63(3):571-7. (PMID: 25732548) J Pharm Pract. 2021 Oct;34(5):741-745. (PMID: 32067567) J Am Pharm Assoc (2003). 2020 Sep - Oct;60(5S):S113-S117. (PMID: 32616446) Hosp Pharm. 1983 Oct;18(10):543-9, 555. (PMID: 10263894) Am J Hosp Pharm. 1982 Oct;39(10):1671-4. (PMID: 6128921) BMJ Open. 2021 Aug 17;11(8):e046630. (PMID: 34404698) Aust N Z J Med. 1998 Aug;28(4):446-52. (PMID: 9777112) J Am Pharm Assoc (2003). 2016 Mar-Apr;56(2):129-36. (PMID: 27000162) Int J Clin Pharm. 2022 Aug;44(4):947-955. (PMID: 35438472) J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4S):S24-S29.e2. (PMID: 30006184) Pharmacotherapy. 2003 Sep;23(9):1175-85. (PMID: 14524649) J Smok Cessat. 2021 Dec 03;2021:9983515. (PMID: 34956405) J Ment Health. 2018 Apr;27(2):164-173. (PMID: 28675321) Alzheimers Res Ther. 2017 May 23;9(1):36. (PMID: 28535785) Ann Pharmacother. 2009 Feb;43(2):194-201. (PMID: 19193572) Front Pharmacol. 2017 Oct 10;8:722. (PMID: 29066976) Epilepsy Res. 2021 Aug;174:106648. (PMID: 33945920) Subst Abuse Rehabil. 2018 Jul 17;9:31-42. (PMID: 30046265) Gen Hosp Psychiatry. 2004 May-Jun;26(3):199-209. (PMID: 15121348) J Am Geriatr Soc. 2010 Jan;58(1):44-53. (PMID: 20002510) Addiction. 2009 Feb;104(2):308-16. (PMID: 19149828) Pharmacotherapy. 2002 Feb;22(2):251-5. (PMID: 11837562) J Taibah Univ Med Sci. 2021 Aug 25;17(2):220-234. (PMID: 35592795) Indian J Psychiatry. 2022 Jan-Feb;64(1):20-24. (PMID: 35400748) Addiction. 2016 Apr;111(4):714-23. (PMID: 26597421) Tob Induc Dis. 2020 Sep 14;18:78. (PMID: 33013274) Subst Use Misuse. 2021;56(12):1846-1859. (PMID: 34348564) Int J Environ Res Public Health. 2022 Oct 08;19(19):. (PMID: 36232195) Am J Health Syst Pharm. 2021 Feb 19;78(Suppl 1):S10-S15. (PMID: 33037816) Am J Hosp Pharm. 1978 Jun;35(6):704-8. (PMID: 665683) Aust J Rural Health. 2006 Dec;14(6):263-9. (PMID: 17121506) Fed Pract. 2017 Oct;34(Suppl 8):S32-S37. (PMID: 30766314) Healthcare (Basel). 2022 Jan 13;10(1):. (PMID: 35052310) Ann Pharmacother. 2012 Sep;46(9):1198-204. (PMID: 22911338) Am J Health Syst Pharm. 2001 Jul 15;58(14):1309-16. (PMID: 11471478) Am J Hosp Pharm. 1982 Sep;39(9):1483-6. (PMID: 6127948) Eur J Clin Pharmacol. 2017 Jul;73(7):827-835. (PMID: 28391409) |
| فهرسة مساهمة: | Keywords: patient-level outcome; pharmacist; psychiatry; systematic review |
| تواريخ الأحداث: | Date Created: 20240205 Latest Revision: 20240206 |
| رمز التحديث: | 20240206 |
| مُعرف محوري في PubMed: | PMC10836561 |
| DOI: | 10.9740/mhc.2024.02.033 |
| PMID: | 38312443 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2168-9709 |
|---|---|
| DOI: | 10.9740/mhc.2024.02.033 |